KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Asset Utilization Ratio (2016 - 2026)

Fulgent Genetics' Asset Utilization Ratio history spans 11 years, with the latest figure at 0.2 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio fell 16.91% to 0.2 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.2, a 16.91% decrease, with the full-year FY2025 number at 0.27, up 14.85% from a year prior.
  • Asset Utilization Ratio hit 0.2 in Q1 2026 for Fulgent Genetics, up from 0.2 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for FLGT hit a ceiling of 0.74 in Q4 2022 and a floor of 0.16 in Q3 2023.
  • Historically, Asset Utilization Ratio has averaged 0.33 across 5 years, with a median of 0.24 in 2024.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 72.24% in 2023 and later soared 39.72% in 2024.
  • Tracing FLGT's Asset Utilization Ratio over 5 years: stood at 0.74 in 2022, then tumbled by 69.68% to 0.22 in 2023, then rose by 3.61% to 0.23 in 2024, then fell by 14.54% to 0.2 in 2025, then grew by 1.46% to 0.2 in 2026.
  • Business Quant data shows Asset Utilization Ratio for FLGT at 0.2 in Q1 2026, 0.2 in Q4 2025, and 0.26 in Q3 2025.